Lion Group Holding Ltd. — FY2020 Form 20-F
Reporting period: Fiscal year ended December 31, 2020. This is an annual report, not a standalone fourth-quarter filing; the source does not provide clear Q4-only financial results. Figures are in U.S. dollars unless stated otherwise. Financial statements are audited and prepared under U.S. GAAP.
Business context
Lion operates a Hong Kong- and Cayman-regulated online trading and financial services platform serving primarily Chinese investors. Its activities include CFD trading and market making, insurance brokerage, futures and securities brokerage, and, from July 2020, total return swaps (TRS). The June 2020 business combination was accounted for as a reverse recapitalization, with Lion Financial Group Limited treated as the accounting predecessor.
Key financial metrics
| Metric | FY2020 | FY2019 |
|---|---|---|
| Revenue | $10.23 million | $18.53 million |
| Expenses | $13.58 million | $10.25 million |
| Operating / pretax loss (income) | $(3.35) million | $8.28 million income |
| Net loss (income) | $(3.35) million | $8.22 million income |
| Basic and diluted loss (earnings) per share | $(0.33) | $1.16 |
| Operating cash flow | $0.11 million | $7.98 million |
| Investing cash flow | $(6.55) million | $(27.25) million |
| Financing cash flow | $2.64 million | $20.66 million |
| Cash and cash equivalents at year-end | $3.43 million | $6.39 million |
Revenue fell 44.8% year over year. Net margin was approximately negative 32.8%, versus positive 44.4% in 2019. Management’s non-GAAP measure, which excludes stock-based compensation and debt-discount amortization, showed $0.32 million of income in 2020; GAAP net loss was $3.35 million.
- Revenue mix: CFD trading and other services contributed $7.03 million (68.7%); insurance brokerage $0.96 million (9.3%); and futures and securities brokerage $2.03 million (19.9%). TRS-related revenue was not yet significant.
- Expenses: Compensation rose to $3.80 million, including $3.66 million of stock-based compensation. General and administrative expense increased to $2.26 million; professional fees to $1.57 million; and technology expense to $1.45 million. Commission expense declined to $1.85 million.
- Balance sheet and liquidity: Total assets were $22.91 million, current assets $16.61 million, total liabilities $12.13 million, current liabilities $11.32 million, and equity $10.77 million. Cash excluding customer funds was $3.43 million; restricted cash held for customers was $1.37 million. Cash and restricted cash together totaled $4.79 million.
- Debt and other obligations: Year-end current short-term borrowings were $0.29 million and the convertible debenture’s carrying value was $0.82 million. The $3.85 million payable to broker-dealers and clearing organizations was primarily related to loans from TRS funding partners; customer payables were $5.22 million. These operating and client-related payables should not be conflated with conventional corporate borrowings.
- Capital and commitments: Regulated subsidiaries maintained $10.91 million of capital against $1.34 million in minimum requirements, and the company reported compliance at year-end. Operating lease commitments totaled $0.86 million, mostly due within one year.
Material changes versus prior year
- CFD and other revenue declined 45.2% to $7.03 million. CFD volume fell from 806,111 lots in 2019 to 223,018 in 2020; management cited COVID-19 impacts, reduced activity by key clients, and limited customer-acquisition opportunities.
- Insurance brokerage revenue declined 63.8% to about $0.96 million, reflecting Hong Kong travel restrictions and political conditions, as well as the company’s strategic shift.
- Futures and securities brokerage revenue decreased 8.4% to $2.03 million. Futures contracts executed declined to 738,444 from 911,693.
- Total expenses increased 32.6% despite lower revenue, producing a return to a GAAP net loss after 2019 profitability. The 2019 result included a $0.77 million interest income/expense spread from a bridge-loan arrangement and a $0.03 million debt-forgiveness gain.
- Operating cash flow fell from $7.98 million to $0.11 million. Investing outflow included $5.95 million advanced for trading software; year-end other assets included this advance. Total stated software acquisition price was approximately $8.0 million, with settlement completed subsequently.
- Year-end unrestricted cash declined from $6.39 million to $3.43 million. Total liabilities increased from $6.23 million to $12.13 million, including new TRS-related broker-dealer payables and the convertible debenture.
Outlook, risks and unusual items
- Outlook: No formal numeric revenue or earnings guidance is provided. Management expected TRS to contribute more in 2021 and later years, planned continued investment in technology and talent, and pursued geographic expansion, including a Singapore Capital Markets Services license application. These are plans, not assured outcomes.
- COVID-19 and market sensitivity: The filing attributes lower trading, insurance and futures activity to the pandemic, uncertainty, travel restrictions and reduced customer willingness or ability to invest. Future effects were not reasonably estimable.
- Regulatory exposure: The business is heavily regulated. A February 2021 CIMA inspection identified areas for improvement, with changes due by August 4, 2021; implementation was ongoing when the report was filed. The company also warned of uncertainty over serving PRC residents, foreign-exchange restrictions, and potential licensing requirements.
- Trading and funding risks: The company sometimes acts as counterparty in CFD trades, including leveraged forex trading of up to 100:1 for certain clients. Market gaps, liquidity, pricing or risk-management failures could cause losses. TRS activity depends on third-party funding and collateral.
- Customer and counterparty concentration: No trading customer exceeded 10% of 2020 revenue, compared with two customers representing 35% in 2019. One clearing broker accounted for 73% of 2020 commission expense; one insurance provider represented 77% of insurance brokerage sales, equivalent to 7% of total revenue.
- Financing and dilution: In December 2020, the company issued a $1.6 million, 9% senior secured convertible debenture, convertible into up to 800,000 ADSs, alongside substantial warrants and anti-dilution provisions. Subsequent to year-end, the company reported $27.4 million from exercise of December warrants, approximately $1.5 million from August warrant exercises, and $6.44 million in a February 2021 financing for preferred shares and warrants. These transactions materially affect liquidity, debt, dilution and potential share supply.
- Controls and governance: Management concluded internal control over financial reporting was effective as of December 31, 2020, following remediation of two prior material weaknesses. Management and the auditor identified a significant deficiency concerning documentation supporting transactions with a director; remediation was underway. The auditor did not provide an ICFR attestation because the company is an emerging growth company.
- Other items: The company reported no material pending legal proceedings. It paid $0.39 million in dividends to its individual shareholder in 2020 and had no dividend policy. Subsequent developments included sponsoring two SPACs and a $3.5 million investment in Grandshores Technology Group, both involving new business and investment risks.
Most important facts for investors to verify
- Reconcile the 2020 revenue decline and loss with the sharp fall in CFD volumes, and assess whether 2021 activity and TRS revenue recovered.
- Review unrestricted cash, operating cash generation, the composition and liquidity of broker-dealer receivables/payables, and repayment or refinancing of borrowings.
- Assess the full terms and post-year-end effects of the secured debenture, preferred shares, warrant exercises, conversion terms and potential dilution.
- Confirm completion of CIMA’s required improvements and monitor PRC-related licensing, foreign-exchange and cross-border operating risks.
- Track remediation of the director-transaction documentation deficiency and test the sustainability of results excluding the $3.66 million stock-based compensation charge.